welcome
Investor's Business Daily

Investor's Business Daily

Business

Business & Economics

AstraZeneca stock jumps more than 4.5% in premarket trades after beating expectations

Investor's Business Daily
Summary
Nutrition label

73% Informative

AstraZeneca ( AZN ) reported core earnings of $ 2.09 per share on $14.89 billion in fourth-quarter sales.

Both measures beat expectations, according to FactSet .

Earnings rocketed 44% on a strict, as-reported basis, while sales climbed 24% .

VR Score

79

Informative language

87

Neutral language

4

Article tone

formal

Language

English

Language complexity

33

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links